Edgewise Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
13.45
0.42
(3.22%)
Volume:
990,800
52 week range:
10.60 - 38.12
Market Cap:
1.281B
Company Description:
Edgewise Therapeutics, Inc. develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy.